You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 346 Enhanced anti-tumor activity of HBsAg specific TCR-T (SCG101) in hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) by preventing T cell exhaustion through PD-1/PD-L1 axis blockade

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cell Therapies
346 Enhanced anti-tumor activity of HBsAg specific TCR-T (SCG101) in hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) by preventing T cell exhaustion through PD-1/PD-L1 axis blockade
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2024

AbstractFullPdf
Nov 2022224018
Dec 202264011
Jan 20236609
Feb 20235403
Mar 20232402
Apr 20235405
May 20236606
Jun 202310208
Jul 202386011
Aug 20234405
Sep 20234207
Oct 20237005
Nov 2023104018
Dec 202350011
Jan 20243605
Feb 202455804
Mar 202460047
Apr 202456015
May 20245808
Jun 20243406
Jul 20245203
Aug 20242403
Sep 20244206
Oct 202448010
Nov 202452012
Total20700238